>
Medistim ASA logo

MEDI - Medistim ASA Share Price

NOK256 3.0  1.2%

Last Trade - 15/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap ÂŁ398.9m
Enterprise Value ÂŁ396.1m
Revenue ÂŁ31.4m
Position in Universe 537th / 1827
Bullish
Bearish
Unlock MEDI Revenue
Momentum
Relative Strength (%)
1m -8.29%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -12.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
251.4 268.1 301.5 325.9 363.7 363.1 461 504 +7.6%
+35.5 -7.9 +21.6 +19.8 +23.2 -1.6 +36.7 +11.2
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, MedistimASA revenues decreased less than 1% to NOK363.1M. Netincome decreased 1% to NOK69.4M. Revenues reflect Europesegment increase of 10% to NOK105.7M, Asia segment increaseof 12% to NOK46.8M, also reflect Third Part Productssegment decrease of 1% to NOK67.5M, Own Products segmentdecrease of less than 1% to NOK295.6M, USA segment decreaseof 7% to NOK126.4M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for MEDI
Graphical History

Revenue

MEDI Revenue Unlock MEDI Revenue

Net Income

MEDI Net Income Unlock MEDI Revenue

Normalised EPS

MEDI Normalised EPS Unlock MEDI Revenue

PE Ratio Range

MEDI PE Ratio Range Unlock MEDI Revenue

Dividend Yield Range

MEDI Dividend Yield Range Unlock MEDI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MEDI EPS Forecasts Unlock MEDI Revenue
Profile Summary

Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The Company provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated February 19, 1995
Public Since May 28, 2004
No. of Shareholders: 1,047
No. of Employees: 118
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Oslo Stock Exchange
Shares in Issue 18,210,836
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MEDI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MEDI
Upcoming Events for MEDI
Wednesday 28th April, 2021
Q1 2021 Medistim ASA Earnings Release
Wednesday 28th April, 2021
Dividend For MEDS.OL - 3.0000 NOK
Wednesday 28th April, 2021 Estimate
Medistim ASA Annual Shareholders Meeting
Friday 13th August, 2021
Q2 2021 Medistim ASA Earnings Release
Frequently Asked Questions for Medistim ASA
What is the Medistim ASA share price?

As of 15/04/21, shares in Medistim ASA are trading at NOK256, giving the company a market capitalisation of ÂŁ398.9m. This share price information is delayed by 15 minutes.

How has the Medistim ASA share price performed this year?

Shares in Medistim ASA are currently trading at NOK256 and the price has moved by 45.04% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Medistim ASA price has moved by 10.15% over the past year.

What are the analyst and broker recommendations for Medistim ASA?

Of the analysts with advisory recommendations for Medistim ASA, there are there are currently 0 "buy" , 0 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Medistim ASA is Strong Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Medistim ASA next release its financial results?

Medistim ASA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Medistim ASA dividend yield?

The Medistim ASA dividend yield is 1.19% based on the trailing twelve month period.

Does Medistim ASA pay a dividend?

Last year, Medistim ASA paid a total dividend of 3, and it currently has a trailing dividend yield of 1.19%. Looking ahead, shares in Medistim ASA are due to go ex-dividend on 2021-04-28 and the next dividend pay date is 2021-05-01.

When does Medistim ASA next pay dividends?

Medistim ASA are due to go ex-dividend on 2021-04-28 and the next dividend pay date is 2021-05-01. The historic dividend yield on Medistim ASA shares is currently 1.19%.

How do I buy Medistim ASA shares?

To buy shares in Medistim ASA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Medistim ASA?

Shares in Medistim ASA are currently trading at NOK256, giving the company a market capitalisation of ÂŁ398.9m.

Where are Medistim ASA shares listed? Where are Medistim ASA shares listed?

Here are the trading details for Medistim ASA:

Country of listing: Norway
Exchange: OSL
Ticker Symbol: MEDI
What kind of share is Medistim ASA?

Based on an overall assessment of its quality, value and momentum, Medistim ASA is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Medistim ASA share price forecast 2021?

Shares in Medistim ASA are currently priced at NOK256. At that level they are trading at 15.42% premium to the analyst consensus target price of 0.00.

Analysts covering Medistim ASA currently have a consensus Earnings Per Share (EPS) forecast of 5.2 for the next financial year.

How can I tell whether the Medistim ASA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medistim ASA. Over the past six months, the relative strength of its shares against the market has been -6.46%. At the current price of NOK256, shares in Medistim ASA are trading at 6.27% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Medistim ASA PE Ratio?

The Medistim ASA PE ratio based on its reported earnings over the past 12 months is 66.5. The shares are currently trading at NOK256.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Medistim ASA?

Medistim ASA's management team is headed by:

Oyvin Broymer - CHM
Thomas Jakobsen - CFO
Anders Lillebo - VPR
Kari Krogstad - PRE
Lars Ronn - DRC
Haege Krogh Wetterhus - VPR
Roger Morberg - VPR
Ole Robsrud - CEX
Siri Furst - DRC
Mike Farbelow - CEX
Bjorn Wiggen - VCH
Tove Raanes - DRC
Tone Veiteberg - VPR
Who are the major shareholders of Medistim ASA?

Here are the top five shareholders of Medistim ASA based on the size of their shareholding:

Aeternum Capital AS Investment Advisor
Percentage owned: 10.16% (1.86m shares)
ODIN Norden Mutual Fund
Percentage owned: 9.82% (1.80m shares)
ODIN Forvaltning AS Investment Advisor
Percentage owned: 9.82% (1.80m shares)
Intertrade Shipping AS Corporation
Percentage owned: 7.01% (1.29m shares)
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund
Percentage owned: 6.19% (1.14m shares)
Similar to MEDI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.